賢豐控股(002141.SZ):豐信致遠清算資產已退回公司賬户
格隆匯12月24日丨賢豐控股(002141.SZ)公佈,近日,公司收到豐信致遠管理人豐信資產出具的《豐信致遠私募(投資)基金清算報告》,豐信致遠清算資產已退回公司賬户。
截至公告日,公司及子公司以閒置自有資金進行風險投資未到期金額共計0萬元整(不含本次清算金額900萬元),未超過公司2019年年度股東大會審議通過的進行風險投資的總額度人民幣5億元。
此次事項全額回收風險投資資金,在一定程度上提高資金使用效率。此次事項預計將會增加2019年利潤總額人民幣4.15萬元(未審計),最終對公司2019年全年損益的影響將以年度審計後的結果為準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.